Open Label Trial of Nissle 1917

• Status: Completed
• Trial end date: 2015-02-01

Summary

Nissle 1917 is an E. coli based probiotic used in the Europe for close to 100 years to treat gastrointestinal disorders and infections. The investigators will assess the safety and tolerability of this medication in Americans in a Phase 1 trial.

• Phase: Phase 1

Details

• Lead Sponsor: Elizabeth Lucas